One Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History

One Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $37,660 - $42,708	-514 Reduced 14.72%	2,977 $241,000
Q3 2023 Nov 01, 2023	BUY	$73.94 - $80.67 $258,124 - $281,618	3,491 New	3,491 $261,000
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $3,897 - $4,370	-63 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $3,939 - $4,413	63 New	63 $4,000
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $316,805 - $413,407	-5,233 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$71.28 - $78.92 $275,853 - $305,420	-3,870 Reduced 42.51%	5,233 $404,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $29,844 - $34,812	460 Added 5.32%	9,103 $645,000
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $107,147 - $130,624	1,471 Added 20.51%	8,643 $652,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $510,287 - $599,005	7,172	7,172 $514,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of One Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on One Wealth Advisors, LLC with notifications on news.